RespireRx Pharmaceuticals Inc. | Business Contracts

Common Stock Purchase Warrant, dated April 14, 2022 (Filed With SEC on April 15, 2022)

Description of Registrants Securities (Filed With SEC on April 15, 2022)

First Amendment to Settlement Agreement and Release, dated as of December 16, 2019, between RespireRx Pharmaceuticals Inc. and Salamandra, LLC (Filed With SEC on October 14, 2020)

Employment Agreement, dated May 6, 2020, between RespireRx Pharmaceuticals Inc.and Timothy Jones (Filed With SEC on October 14, 2020)

Patent License Agreement, dated as of August 1, 2020, by and between the University of Wisconsin-Milwaukee Research Foundation, Inc. and RespireRx Pharmaceuticals Inc (Filed With SEC on October 14, 2020)

Agreement and Plan of Merger, dated as of August 10, 2012, by and among Cortex Pharmaceuticals, Inc., Pier Acquisition Corp. and Pier Pharmaceuticals, Inc (Filed With SEC on October 14, 2020)

Promissory Note dated, April 14, 2022 (Filed With SEC on April 15, 2022)

Piggy-back Registration Rights Agreement dated April 14, 2022 between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC (Filed With SEC on April 15, 2022)

Securities Purchase Agreement dated April 14, 2022, between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC (Filed With SEC on April 15, 2022)

Description of Registrants Securities (Filed With SEC on April 15, 2021)

Letter Agreement, dated October 23, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 26, 2020)

Letter Agreement, dated October 21, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 26, 2020)

Escrow Deposit Agreement, dated October 23, 2020, between RespireRx Pharmaceuticals Inc. and Signature Bank (Filed With SEC on October 26, 2020)

Common Stock Purchase Warrant, dated October 22, 2019 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated June 7, 2020, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated April 15, 2020, in favor of Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated April 15, 2020, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Form of Exchange Agreement (Filed With SEC on October 14, 2020)

Company Option Agreement, dated as of March 2, 2020, by and between the UWM Research Foundation, Inc. and RespireRx Pharmaceuticals Inc (Filed With SEC on October 14, 2020)

RespireRx Pharmaceuticals Inc. 10% Convertible Redeemable Note due November 4, 2020, dated November 4, 2019 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated November 4, 2019, between RespireRx Pharmaceuticals Inc. and Odyssey Funding, LLC (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated August 19, 2019 (Filed With SEC on October 14, 2020)

10% Convertible Note, dated October 22, 2019 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated October 22, 2019, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC (Filed With SEC on October 14, 2020)

Settlement Agreement and Release, dated August 21, 2019, between RespireRx Pharmaceuticals Inc. and Salamandra, LLC (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated August 19, 2019 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated July 2, 2020, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated August 19, 2019, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated May 17, 2019 (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated May 17, 2019 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated May 17, 2019, between RespireRx Pharmaceuticals Inc. and Crown Bridge Partners, LLC (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated April 24, 2019 (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated June 7, 2020, in favor of Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated July 30, 2020, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC (Filed With SEC on October 14, 2020)

Amendment No. 1 to 8% Fixed Promissory Note, dated September 30, 2020 (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Patent Network Law Group (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Marc Radin PC (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Arnold S. Lippa (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Jeff Eliot Margolis (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Timothy Jones (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated July 30, 2020, in favor of EMA Financial, LLC (Filed With SEC on October 14, 2020)

10% Convertible Note, dated July 30, 2020, in favor of EMA Financial, LLC (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)

8% Fixed Promissory Note, dated July 28, 2020, in favor of White Lion Capital, LLC (Filed With SEC on October 14, 2020)

Registration Rights Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 14, 2020)

Equity Purchase Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 14, 2020)

Fifth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

Fourth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

Amendment No. 1 to Employment Agreement of Timothy Jones, effective July 31, 2020 (Filed With SEC on October 14, 2020)

Form of Convertible Promissory Note (including the Form of Warrant) (Filed With SEC on October 14, 2020)

Exchange Agreement, dated July 13, 2020, between RespireRx Pharmaceuticals Inc. and Arnold S. Lippa (Filed With SEC on October 14, 2020)

Exchange Agreement, dated July 13, 2020, between RespireRx Pharmaceuticals Inc. and Jeff Eliot Margolis (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated April 24, 2019, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Form of Convertible Promissory Note (including a Form of Warrant) (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated January 15, 2010, by and between the Company and Samyang Optics Co., Ltd., including a form of Convertible Promissory Note attached as Exhibit... (Filed With SEC on October 14, 2020)

Release Agreement, dated September 2, 2014, between the Company and the Institute for the Study of Aging Inc (Filed With SEC on October 14, 2020)

Form of Restricted Stock Award Agreement (Filed With SEC on October 14, 2020)

Form of Incentive Stock Option Award Agreement (Filed With SEC on October 14, 2020)

Form of Non-Statutory Stock Option Award Agreement (Filed With SEC on October 14, 2020)

Standard Agreement for Submitting Compounds for Preclinical Pharmacological, Pharmacokinetic and Toxicological Evaluation, dated October 19, 2015, by and between the National... (Filed With SEC on October 14, 2020)

Exclusive License Agreement, dated as of June 27, 2014, by and between the Board of Trustees of the University of Illinois, a body corporate and politic of the State of Illinois,... (Filed With SEC on October 14, 2020)

Cortex Pharmaceuticals, Inc. 2014 Equity, Equity-Linked and Equity Derivative Incentive Plan, established March 14, 2014 (Filed With SEC on October 14, 2020)

Form of Securities Purchase Agreement (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated June 25, 2012, by and between the Company and Samyang Optics Co., Ltd., including a form of Secured Promissory Note attached as Exhibit A... (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated October 20, 2011, by and between the Company and Samyang Value Partners Co., Ltd., including the Common Stock Purchase Warrant attached as... (Filed With SEC on October 14, 2020)

Patent Assignment and Option and Amended and Restated Agreement, dated June 10, 2011, between the Company and Les Laboratoires Servier (Filed With SEC on October 14, 2020)

Demand Promissory Note, dated June 16, 2015, held by Arnold S. Lippa on behalf of the Company (Filed With SEC on October 14, 2020)

Asset Purchase Agreement, dated March 15, 2011, by and between the Company and Biovail Laboratories International SRL (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated July 29, 2009, by and between the Company and the Investors named therein (Filed With SEC on October 14, 2020)

Patent License Agreement between the Company and the University of Alberta, dated as of May 9, 2007 (Filed With SEC on October 14, 2020)

Amendment No. 3 to the Companys 2006 Stock Incentive Plan, effective May 19, 2010 (Filed With SEC on October 14, 2020)

Amendment No. 2 to the Companys 2006 Stock Incentive Plan, effective as of June 5, 2009 (Filed With SEC on October 14, 2020)

Amendment No. 1 to the Companys 2006 Stock Incentive Plan, dated May 9, 2007 (Filed With SEC on October 14, 2020)

Form of Incentive/Non-qualified Stock Option Agreement under the Companys 2006 Stock Incentive Plan (Filed With SEC on October 14, 2020)

Form of Notice of Grant of Stock Options and Option Agreement under the Companys 2006 Stock Incentive Plan (Filed With SEC on October 14, 2020)

Cortex Pharmaceuticals, Inc. 2006 Stock Incentive Plan (Filed With SEC on October 14, 2020)

Placement Agency Agreement, dated April 13, 2009, by and between the Company and Rodman & Renshaw, LLC, Form of Securities Purchase Agreement and Form of Common Stock Purchase... (Filed With SEC on October 14, 2020)

Placement Agency Agreement, dated August 24, 2007, by and between Cortex Pharmaceuticals, Inc. and JMP Securities LLC and Rodman and Renshaw, LLC, Form of Subscription Agreement... (Filed With SEC on October 14, 2020)

Form of Convertible Note and Warrant Agreement, including a form of 10% Convertible Note due September 15, 2012 attached as Exhibit A thereto and a Form of Warrant to Purchase... (Filed With SEC on October 14, 2020)

Form of Demand Promissory Note (Filed With SEC on October 14, 2020)

Development and Supply Agreement, dated September 4, 2018 (Filed With SEC on October 14, 2020)

Form of Exchange Agreement, including a Form of New Warrant attached as Exhibit A thereto (Filed With SEC on October 14, 2020)

Form of Purchase Agreement (including a Form of Warrant) (Filed With SEC on October 14, 2020)

Form of Note Exchange Agreement (Filed With SEC on October 14, 2020)

Form of Demand Promissory Note (Filed With SEC on October 14, 2020)

Second Amendment of the Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

Form of Purchase Agreement (including a Form of Warrant) (Filed With SEC on October 14, 2020)

Amendment No. One of the Employment Agreement of Jeff E. Margolis, effective July 1, 2017 (Filed With SEC on October 14, 2020)

Form of Purchase Agreement (including a Form of Warrant) (Filed With SEC on October 14, 2020)

Form of Exchange Agreement (Filed With SEC on October 14, 2020)

Form of Common Stock and Warrant Purchase Agreement, including a Form of Warrant to Purchase Common Stock attached as Exhibit A thereto (Filed With SEC on October 14, 2020)

Form of Warrant to Purchase Common Stock (Filed With SEC on October 14, 2020)

Form of Common Stock and Warrant Purchase Agreement, including a Form of Warrant to Purchase Common Stock attached as Exhibit A thereto (Filed With SEC on October 14, 2020)

Form of Second Amended and Restated Common Stock and Warrant Purchase Agreement (Filed With SEC on October 14, 2020)

Employment Agreement, dated August 18, 2015, between the Company and Jeff E. Margolis (Filed With SEC on October 14, 2020)

Employment Agreement, dated August 18, 2015, between the Company and Robert N. Weingarten (Filed With SEC on October 14, 2020)

Employment Agreement, dated August 18, 2015, between the Company and Arnold S. Lippa (Filed With SEC on October 14, 2020)

Employment Agreement, dated August 18, 2015, between the Company and James S. J. Manuso (Filed With SEC on October 14, 2020)

Form of Non-Statutory Stock Option Award Agreement (Filed With SEC on October 14, 2020)

First Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

2015 Stock and Stock Option Plan, dated June 30, 2015 (Filed With SEC on October 14, 2020)

Description of Registrants Securities (Filed With SEC on April 14, 2020)

RespireRx Pharmaceuticals Inc. (107)